Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elizabeth KC Schwartz, Noah R Wolkowicz, Joao P De Aquino, R Ross MacLean & Mehmet Sofuoglu. (2022) Cocaine Use Disorder (CUD): Current Clinical Perspectives. Substance Abuse and Rehabilitation 13, pages 25-46.
Read now
Read now
Dakwar Elias & Herbert D. Kleber. (2017) Minding the brain: the role of pharmacotherapy in substance-use disorder treatment. Dialogues in Clinical Neuroscience 19:3, pages 289-297.
Read now
Read now
JoyM. Schmitz, MarcE. Mooney, CharlesE. Green, ScottD. Lane, JoelL. Steinberg, AlanC. Swann & F.
Gerard Moeller. (2009) Baseline Neurocognitive Profiles Differentiate Abstainers and Non-Abstainers in a Cocaine Clinical Trial. Journal of Addictive Diseases 28:3, pages 250-257.
Read now
Read now
C. E. Green, F. G. Moeller, J. M. Schmitz, J. F. Lucke, S. D. Lane, A. C. Swann, R. E. Lasky & J. P. Carbonari. (2009) Evaluation of Heterogeneity in Pharmacotherapy Trials for Drug Dependence: A Bayesian Approach. The American Journal of Drug and Alcohol Abuse 35:2, pages 95-102.
Read now
Read now
Articles from other publishers (75)
Joy M. Schmitz, Angela L. Stotts, Anka A. Vujanovic, Jin H. Yoon, Heather E. Webber, Scott D. Lane, Michael F. Weaver, Jessica Vincent, Robert Suchting & Charles E. Green. (2024) Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART). Drug and Alcohol Dependence 256, pages 111078.
Crossref
Crossref
Cheng Hua. 2023. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11
158
237
.
Kevin A. Sevarino & Michael Farrell. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
90
.
Xavier J. Maddern, Leigh C. Walker, Erin J. Campbell, Shalini Arunogiri, Paul S. Haber, Kirsten Morley, Victoria Manning, E. Zayra Millan, Gavan P. McNally, Dan I. Lubman & Andrew J. Lawrence. (2022) Can we enhance the clinical efficacy of cognitive and psychological approaches to treat substance use disorders through understanding their neurobiological mechanisms?. Neuroscience & Biobehavioral Reviews 142, pages 104899.
Crossref
Crossref
N. Pintori, A. Piva, V. Guardiani, C. M. Marzo, I. Decimo & C. Chiamulera. (2022) The interaction between Environmental Enrichment and fluoxetine in inhibiting sucrose-seeking renewal in mice depend on social living condition. Psychopharmacology 239:7, pages 2351-2361.
Crossref
Crossref
Dimy Fluyau, Paroma Mitra, Ankit Jain, Vasanth Kattalai Kailasam & Christopher G. Pierre. (2022) Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis. European Journal of Clinical Pharmacology 78:6, pages 931-942.
Crossref
Crossref
Hongsong Feng, Kaifu Gao, Dong Chen, Li Shen, Alfred J Robison, Edmund Ellsworth & Guo-Wei Wei. (2022) Machine Learning Analysis of Cocaine Addiction Informed by DAT, SERT, and NET-Based Interactome Networks. Journal of Chemical Theory and Computation 18:4, pages 2703-2719.
Crossref
Crossref
Robert Suchting, Charles E. Green, Constanza de Dios, Jessica Vincent, F. Gerard Moeller, Scott D. Lane & Joy M. Schmitz. (2021) Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial. Drug and Alcohol Dependence 228, pages 109054.
Crossref
Crossref
Yue Li, Linda D. Simmler, Ruud Van ZessenJérôme Flakowski, Jin-Xia Wan, Fei Deng, Yu-Long Li, Katherine M. Nautiyal, Vincent Pascoli & Christian Lüscher. (2021) Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction. Science 373:6560, pages 1252-1256.
Crossref
Crossref
Susana Barbosa-Méndez, Casandra López-Morado & Alberto Salazar-Juárez. (2021) Mirtazapine-induced decrease in cocaine sensitization is enhanced by environmental enrichment in rats. Pharmacology Biochemistry and Behavior 208, pages 173237.
Crossref
Crossref
Laura Brandt, Thomas Chao, Sandra D. Comer & Frances R. Levin. (2020) Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction 116:4, pages 694-710.
Crossref
Crossref
John J. Mariani, Martina Pavlicova, C. Jean Choi, Cale Basaraba, Kenneth M. Carpenter, Amy L. Mahony, Daniel J. Brooks, Adam Bisaga, Nasir Naqvi, Edward V. Nunes & Frances R. Levin. (2021) Quetiapine treatment for cannabis use disorder. Drug and Alcohol Dependence 218, pages 108366.
Crossref
Crossref
David A. Gorelick. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
173
186
.
Derek Blevins, Kenneth M. Carpenter, Diana Martinez, John J. Mariani & Frances R. Levin. (2020) An adaptive clinical trial design for cocaine use disorder: Extended-release amphetamine salts for early behavioral intervention non-responders. Contemporary Clinical Trials 98, pages 106187.
Crossref
Crossref
A.D. Snyder, E. Zuniga, L. Ma, J.L. Steinberg, K. Woisard, P.A. Narayana, S. Lane, J. Schmitz & F.G. Moeller. (2020) Examination of preliminary behavioral and effective connectivity findings from treatment response to citalopram in cocaine use disorder: A dynamic causal modeling study. Psychiatry Research: Neuroimaging 303, pages 111127.
Crossref
Crossref
Frances R. Levin, John J. Mariani, Martina Pavlicova, C. Jean Choi, Amy L. Mahony, Daniel J. Brooks, Adam Bisaga, Elias Dakwar, Kenneth M. Carpenter, Nasir Naqvi, Edward V. Nunes & Kyle Kampman. (2020) Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug and Alcohol Dependence 206, pages 107700.
Crossref
Crossref
Kathryn A. Cunningham, Leonard L. Howell & Noelle C. Anastasio. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
745
802
.
Francisco J Flores-Ramirez, Israel Garcia-Carachure, David O Sanchez, Celene Gonzalez, Samuel A Castillo, Miguel A Arenivar, Anapaula Themann, Omar Lira, Minerva Rodriguez, Joshua Preciado-Piña & Sergio D Iñiguez. (2018) Fluoxetine exposure in adolescent and adult female mice decreases cocaine and sucrose preference later in life. Journal of Psychopharmacology 33:1, pages 145-153.
Crossref
Crossref
Dennis J. Sholler, Sonja J. Stutz, Robert G. Fox, Edward L. Boone, Qin Wang, Kenner C. Rice, F. Gerard Moeller, Noelle C. Anastasio & Kathryn A. Cunningham. (2019)
The 5-HT
2A
Receptor (5-HT
2A
R) Regulates Impulsive Action and Cocaine Cue Reactivity in Male Sprague-Dawley Rats
. Journal of Pharmacology and Experimental Therapeutics 368:1, pages 41-49.
Crossref
Crossref
Kevin M. Gray. 2019. Cannabis Use Disorders. Cannabis Use Disorders
221
227
.
Vítor Soares Tardelli, Mariana Pimentel Pádua do Lago, Mariel Mendez, Adam Bisaga & Thiago Marques Fidalgo. (2018) Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Behaviour Research and Therapy 111, pages 57-63.
Crossref
Crossref
L. Outar, M.J. Turner, A.G. Wood & R. Lowry. (2018) “I need to go to the gym”: Exploring the use of rational emotive behaviour therapy upon exercise addiction, irrational and rational beliefs. Performance Enhancement & Health 6:2, pages 82-93.
Crossref
Crossref
Aya Matsui & Veronica A. Alvarez. (2018) Cocaine Inhibition of Synaptic Transmission in the Ventral Pallidum Is Pathway-Specific and Mediated by Serotonin. Cell Reports 23:13, pages 3852-3863.
Crossref
Crossref
Barry J. Everitt, Chiara Giuliano & David Belin. (2018) Addictive behaviour in experimental animals: prospects for translation. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1742, pages 20170027.
Crossref
Crossref
Marguerite Ternes, Stephanie Goodwin & Kathleen Hyland. 2018. The Practice of Correctional Psychology. The Practice of Correctional Psychology
39
69
.
Maryam Bashiri, Michael J. Mancino, Virginia A. Stanick, Jeff Thostenson, Thomas R. Kosten & Alison H. Oliveto. (2017) Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. The American Journal on Addictions 26:8, pages 807-814.
Crossref
Crossref
Joanna Jastrzębska, Małgorzata Frankowska, Agata Suder, Karolina Wydra, Ewa Nowak, Małgorzata Filip & Edmund Przegaliński. (2017) Effects of escitalopram and imipramine on cocaine reinforcement and drug-seeking behaviors in a rat model of depression. Brain Research 1673, pages 30-41.
Crossref
Crossref
Perrine Roux, Caroline Lions, Antoine Vilotitch, Laurent Michel, Marion Mora, Gwenaelle Maradan, Fabienne Marcellin, Bruno Spire, Alain Morel & Patrizia M. Carrieri. (2016) Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Harm Reduction Journal 13:1.
Crossref
Crossref
Joshua A. Lile, William W. Stoops, Craig R. Rush, S. Stevens Negus, Paul E.A. Glaser, Kevin W. Hatton & Lon R. Hays. (2016) Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug and Alcohol Dependence 165, pages 111-119.
Crossref
Crossref
Paul W. Czoty, William W. Stoops & Craig R. Rush. (2016) Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacological Reviews 68:3, pages 533-562.
Crossref
Crossref
Elias Dakwar & Edward V. Nunes. (2016) New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders. Current Psychiatry Reports 18:7.
Crossref
Crossref
Luis Pereira Justo. 2016. Innovations in the Treatment of Substance Addiction. Innovations in the Treatment of Substance Addiction
37
49
.
Guy A. Higgins & Paul J. Fletcher. (2015)
Therapeutic Potential of 5-HT
2C
Receptor Agonists for Addictive Disorders
. ACS Chemical Neuroscience 6:7, pages 1071-1088.
Crossref
Crossref
Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry
1561
1614
.
Leonard L. Howell & Kathryn A. Cunningham. (2014)
Serotonin 5-HT
2
Receptor Interactions with Dopamine Function: Implications for Therapeutics in Cocaine Use Disorder
. Pharmacological Reviews 67:1, pages 176-197.
Crossref
Crossref
Christian P. Müller & Judith R. Homberg. (2015) The role of serotonin in drug use and addiction. Behavioural Brain Research 277, pages 146-192.
Crossref
Crossref
Andrew C. McCreary, Christian P. Müller & Małgorzata Filip. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
41
83
.
David A. Gorelick. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
381
404
.
Christopher D. Verrico, Colin N. Haile, James J. Mahoney III, Daisy G.Y. Thompson-Lake, Thomas F. Newton & Richard De La Garza II. (2014) Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence 141, pages 72-78.
Crossref
Crossref
Barry J. Everitt. (2014) Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories – indications for novel treatments of addiction. European Journal of Neuroscience 40:1, pages 2163-2182.
Crossref
Crossref
Michael J. Mancino, Janette McGaugh, Mohit P. Chopra, Joseph B. Guise, Christopher Cargile, D. Keith Williams, Jeff Thostenson, Thomas R. Kosten, Nichole Sanders & Alison Oliveto. (2014) Clinical Efficacy of Sertraline Alone and Augmented With Gabapentin in Recently Abstinent Cocaine-Dependent Patients With Depressive Symptoms. Journal of Clinical Psychopharmacology 34:2, pages 234-239.
Crossref
Crossref
Wilfrid Noel Raby, Eric A. Rubin, Fatima Garawi, Wendy Cheng, Ella Mason, Lisa Sanfilippo, Stephanie Lord, Adam Bisaga, Efrat Aharonovich, Frances Levin, David McDowell & Edward V. Nunes. (2013) A randomized, double‐blind, placebo‐controlled trial of venlafaxine for the treatment of depressed cocaine‐dependent patients. The American Journal on Addictions 23:1, pages 68-75.
Crossref
Crossref
Noelle C Anastasio, Sonja J Stutz, Robert G Fox, Robert M Sears, Ronald B Emeson, Ralph J DiLeone, Richard T O'Neil, Latham H Fink, Dingge Li, Thomas A Green, F Gerard Moeller & Kathryn A Cunningham. (2013) Functional Status of the Serotonin 5-HT2C Receptor (5-HT2CR) Drives Interlocked Phenotypes that Precipitate Relapse-Like Behaviors in Cocaine Dependence. Neuropsychopharmacology 39:2, pages 360-372.
Crossref
Crossref
Kathryn A. Cunningham & Noelle C. Anastasio. (2014) Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology 76, pages 460-478.
Crossref
Crossref
Leonard L. Howell & S. Stevens Negus. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
129
176
.
Barry J. Everitt & Trevor W. Robbins. (2013) From the ventral to the dorsal striatum: Devolving views of their roles in drug addiction. Neuroscience & Biobehavioral Reviews 37:9, pages 1946-1954.
Crossref
Crossref
Shijing Liu, Scott D Lane, Joy M Schmitz, Kathryn A Cunningham, Vineeth P John & F Gerard Moeller. (2013) Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects. Journal of Psychopharmacology 27:9, pages 801-807.
Crossref
Crossref
Stephanie M Groman & J David Jentsch. (2013) Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates. Current Opinion in Neurobiology 23:4, pages 625-631.
Crossref
Crossref
Lourens J. P. Nonkes, Joseph H. R. Maes & Judith R. Homberg. (2011) Improved cognitive flexibility in serotonin transporter knockout rats is unchanged following chronic cocaine self‐administration. Addiction Biology 18:3, pages 434-440.
Crossref
Crossref
Yann Pelloux, Ruth Dilleen, Daina Economidou, David Theobald & Barry J Everitt. (2012) Reduced Forebrain Serotonin Transmission is Causally Involved in the Development of Compulsive Cocaine Seeking in Rats. Neuropsychopharmacology 37:11, pages 2505-2514.
Crossref
Crossref
Wim van den Brink. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
235
261
.
Eileen K Sawyer, Jiyoung Mun, Jonathon A Nye, Heather L Kimmel, Ronald J Voll, Jeffrey S Stehouwer, Kenner C Rice, Mark M Goodman & Leonard L Howell. (2012) Neurobiological Changes Mediating the Effects of Chronic Fluoxetine on Cocaine Use. Neuropsychopharmacology 37:8, pages 1816-1824.
Crossref
Crossref
William W. Stoops, Joshua A. Lile, Paul E. A. Glaser, Lon R. Hays & Craig R. Rush. (2012) Influence of acute bupropion pre‐treatment on the effects of intranasal cocaine. Addiction 107:6, pages 1140-1147.
Crossref
Crossref
John J. Mariani & Frances R. Levin. (2012) Psychostimulant Treatment of Cocaine Dependence. Psychiatric Clinics of North America 35:2, pages 425-439.
Crossref
Crossref
Alison Oliveto, James Poling, Michael J. Mancino, D. Keith Williams, Jeff Thostenson, Rhonda Pruzinsky, Kishorchandra Gonsai, Mehmet Sofuoglu, Gerardo Gonzalez, Shanti Tripathi & Thomas R. Kosten. (2011) Sertraline delays relapse in recently abstinent cocaine‐dependent patients with depressive symptoms. Addiction 107:1, pages 131-141.
Crossref
Crossref
Donna M. Platt & James K. Rowlett. 2012. Nonhuman Primates in Biomedical Research. Nonhuman Primates in Biomedical Research
817
839
.
Ahmed Elkashef & Ivan Montoya. 2012. Drug Abuse and Addiction in Medical Illness. Drug Abuse and Addiction in Medical Illness
107
119
.
Pier Paolo Pani, Emanuela Trogu, Simona Vecchi & Laura Amato. (2011) Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Daryl Shorter & Thomas R Kosten. (2011) Novel pharmacotherapeutic treatments for cocaine addiction. BMC Medicine 9:1.
Crossref
Crossref
Sreedevi Vayalapalli, Michael Vaughn, Khadijeh Salles-Shahid, Johnita Byrd-Sellers & Karen Drexler. (2011) High-Dose Citalopram for Cocaine Dependence in Veteran Population-A Pilot Project. The American Journal on Addictions 20:5, pages 485-486.
Crossref
Crossref
Daniel Ciccarone. (2011) Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at Pharmacotherapy. Primary Care: Clinics in Office Practice 38:1, pages 41-58.
Crossref
Crossref
Kyle M. Kampman. (2010) What’s New in the Treatment of Cocaine Addiction?. Current Psychiatry Reports 12:5, pages 441-447.
Crossref
Crossref
R. Kathryn McHugh, Bridget A. Hearon & Michael W. Otto. (2010) Cognitive Behavioral Therapy for Substance Use Disorders. Psychiatric Clinics of North America 33:3, pages 511-525.
Crossref
Crossref
Thierry Favrod-Coune & Barbara Broers. (2010) The Health Effect of Psychostimulants: A Literature Review. Pharmaceuticals 3:7, pages 2333-2361.
Crossref
Crossref
Kimberly L. Kjome, Scott D. Lane, Joy M. Schmitz, Charles Green, Liangsuo Ma, Irshad Prasla, Alan C. Swann & F. Gerard Moeller. (2010) Relationship between impulsivity and decision making in cocaine dependence. Psychiatry Research 178:2, pages 299-304.
Crossref
Crossref
Alan C. Swann. (2010) The strong relationship between bipolar and substance‐use disorder. Annals of the New York Academy of Sciences 1187:1, pages 276-293.
Crossref
Crossref
Bianca Jupp & Andrew J. Lawrence. (2010) New horizons for therapeutics in drug and alcohol abuse. Pharmacology & Therapeutics 125:1, pages 138-168.
Crossref
Crossref
Christian P. Müller, Martin E. Pum, Gunter Schumann & Joseph P. Huston. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
507
545
.
Ahmed Elkashef & Frank Vocci. 2011. Addiction Medicine. Addiction Medicine
1017
1028
.
Igor Elman, Steven Lowen, Blaise B. Frederick, Won Chi, Lino Becerra & Roger K. Pitman. (2009) Functional Neuroimaging of Reward Circuitry Responsivity to Monetary Gains and Losses in Posttraumatic Stress Disorder. Biological Psychiatry 66:12, pages 1083-1090.
Crossref
Crossref
Jeremy Adams. (2009) Understanding Exercise Dependence. Journal of Contemporary Psychotherapy 39:4, pages 231-240.
Crossref
Crossref
Noushin Yahyavi-Firouz-Abadi & Ronald E. See. (2009) Anti-relapse medications: Preclinical models for drug addiction treatment. Pharmacology & Therapeutics 124:2, pages 235-247.
Crossref
Crossref
Frank J Vocci & Iván D Montoya. (2009) Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Current Opinion in Psychiatry 22:3, pages 263-268.
Crossref
Crossref
Fabrizio Schifano. 2009. Substance Abuse Disorders. Substance Abuse Disorders
53
74
.
Bríd Á. Nic Dhonnchadha & Kathryn A. Cunningham. (2008) Serotonergic mechanisms in addiction-related memories. Behavioural Brain Research 195:1, pages 39-53.
Crossref
Crossref